Nitric oxide (NO) produced by vascular endothelial cells causes vasodilation. Which intracellular mechanism mediates smooth muscle relaxation?
- A NO activates soluble guanylyl cyclase → cGMP → PKG → dephosphorylates myosin light chain → relaxation ✓
- B NO inhibits voltage-gated calcium channels reducing intracellular Ca2+ → smooth muscle relaxation
- C NO activates adenylyl cyclase → cAMP → PKA → myosin light chain kinase inhibition → relaxation
- D NO directly hyperpolarizes smooth muscle cells by activating large-conductance BKCa channels
Explanation
The canonical NO-cGMP signaling pathway: NO (a small lipophilic gaseous molecule) diffuses from endothelial cells into vascular smooth muscle cells, where it directly activates soluble guanylyl cyclase (sGC). sGC converts GTP to cGMP. cGMP activates protein kinase G (PKG), which phosphorylates myosin light chain phosphatase (MLCP) — increasing its activity — and other targets, resulting in dephosphorylation of myosin light chains and smooth muscle relaxation. Options B and D are secondary downstream effects that can occur but are not the primary mechanism. Option C describes the prostacyclin (PGI2) pathway, not NO.
Reference: Guyton & Hall, Textbook of Medical Physiology, 14th ed.
High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP
Written and medically reviewed by the StethoPrep medical team.